新型冠状病毒肺炎的中医病机与辨证诊疗汇总分析

Summary of the pathogenesis and syndrome differentiation of the traditional Chinese medicine in novel coronavirus pneumonia

自2019年12月以来,湖北省武汉市爆发多起不明原因肺炎疫情,后经病原学检测判定为一种新型冠状病毒(2019-nCoV),将由其引发的疫情拟称为新型冠状病毒肺炎(COVID-19),并被国家卫生健康委员会列入乙类传染病,采取甲类传染病的预控制措施。由张伯礼院士等专家组成的专家组深入疫区,开展疫区中医药防控工作,有效控制了疫情的发展与转归,取得显著成效。文章从目前已公布的临床资料出发,比较分析COVID-19患者的临床症状、检查、中医证候、治疗等内容,以期为临床指导COVID-19诊断及治疗提供依据。

Since December 2019,there have been outbreak pneumonia epidemic with unknown cause in Wuhan,Hubei Province.The virus was then determined to belong to a kind of novel coronavirus by etiological detection.The epidemic caused by this virus is called novel coronavirus pneumonia,which is listed as Class B infectious diseases by the National Health and Health Commission and pre-control measures for Class A infectious diseases are taken.The expert group,composed of academician ZHANG Boli and other experts,went deep into the epidemic area and carried out the prevention and control of traditional Chinese medicine in the epidemic area.This measure effectively controlled the development and outcome of the epidemic,and achieved remarkable results.Therefore,based on the published clinical data,this article compares and analyzes the clinical symptoms,examination,traditional Chinese medicine syndromes and treatment of novel coronavirus pneumonia patients,so as to provide basis for clinical guidance of novel coronavirus pneumonia diagnosis and treatment.